RedHill Biopharma (RDHL) Times Interest Earned (2016 - 2023)
Historic Times Interest Earned for RedHill Biopharma (RDHL) over the last 12 years, with Q2 2023 value amounting to $27.91.
- RedHill Biopharma's Times Interest Earned rose 118405.85% to $27.91 in Q2 2023 from the same period last year, while for Jun 2023 it was -$1.2, marking a year-over-year increase of 8069.87%. This contributed to the annual value of -$7.1 million for FY2024, which is 54043268443.75% down from last year.
- Latest data reveals that RedHill Biopharma reported Times Interest Earned of $27.91 as of Q2 2023, which was up 118405.85% from -$69.07 recorded in Q1 2023.
- RedHill Biopharma's Times Interest Earned's 5-year high stood at $167.3 during Q2 2019, with a 5-year trough of -$69.07 in Q1 2023.
- Over the past 5 years, RedHill Biopharma's median Times Interest Earned value was $4.29 (recorded in 2020), while the average stood at $15.0.
- In the last 5 years, RedHill Biopharma's Times Interest Earned soared by 290564.47% in 2019 and then tumbled by 172372.26% in 2023.
- RedHill Biopharma's Times Interest Earned (Quarter) stood at $62.91 in 2019, then plummeted by 93.12% to $4.33 in 2020, then tumbled by 987.5% to -$38.41 in 2021, then increased by 20.52% to -$30.53 in 2022, then surged by 191.42% to $27.91 in 2023.
- Its Times Interest Earned stands at $27.91 for Q2 2023, versus -$69.07 for Q1 2023 and -$30.53 for Q4 2022.